Cedar Mountain Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Hold
34
﹤0.01% 448
2026
Q1
$12K Buy
34
+30
+750% +$10.7K ﹤0.01% 413
2025
Q4
$1.31K Hold
4
﹤0.01% 461
2025
Q3
$1.13K Sell
4
-37
-90% -$10.7K ﹤0.01% 507
2025
Q2
$11.4K Hold
41
﹤0.01% 205
2025
Q1
$12.8K Sell
41
-3
-7% -$886 ﹤0.01% 187
2024
Q4
$11.5K Sell
44
-8
-15% -$2.37K ﹤0.01% 200
2024
Q3
$16.8K Hold
52
﹤0.01% 164
2024
Q2
$16.2K Hold
52
﹤0.01% 153
2024
Q1
$14.8K Hold
52
﹤0.01% 164
2023
Q4
$15K Hold
52
﹤0.01% 152
2023
Q3
$14K Hold
52
﹤0.01% 143
2023
Q2
$11.5K Hold
52
﹤0.01% 159
2023
Q1
$12.6K Hold
52
﹤0.01% 144
2022
Q4
$13.7K Hold
52
﹤0.01% 135
2022
Q3
$12K Hold
52
﹤0.01% 138
2022
Q2
$13K Sell
52
-27
-34% -$6.62K ﹤0.01% 137
2022
Q1
$19K Hold
79
0.01% 126
2021
Q4
$18K Hold
79
0.01% 135
2021
Q3
$17K Buy
79
+27
+52% +$6.21K 0.01% 130
2021
Q2
$13K Hold
52
﹤0.01% 141
2021
Q1
$13K Hold
52
﹤0.01% 153
2020
Q4
$12K Hold
52
﹤0.01% 158
2020
Q3
$13K Hold
52
0.01% 136
2020
Q2
$12K Buy
52
+26
+100% +$5.93K 0.01% 131
2020
Q1
$5K Hold
26
﹤0.01% 155
2019
Q4
$6K Buy
+26
New +$5.73K ﹤0.01% 162

Other funds holding AMGN

Cedar Mountain Advisors's AMGN Position: Q2 2026 in Review

Cedar Mountain Advisors held its Amgen (AMGN) position steady in Q2 2026 at 34 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

Cedar Mountain Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $19K in Q1 2022. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cedar Mountain Advisors held 34 shares of Amgen worth $12.3K as of Q2 2026.
  • Cedar Mountain Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #448 holding.
  • Cedar Mountain Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Cedar Mountain Advisors's Amgen position peaked at $19K in Q1 2022.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.